Tranexamic Acid for Blood Loss Minimization in Endoscopic Pituitary Surgery

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This trial is to determine the effect of Tranexamic Acid (TXA) on blood loss during endoscopic pituitary surgery. The hypothesis of this study is that TXA will reduce blood loss during surgery compared to a placebo. To answer this hypothesis, the investigators are conducting a randomized controlled trial in which half of participants will receive TXA and half will receive placebo (saline) in a double blind fashion.
Epistemonikos ID: 68f26630d8b61242e06b8933e7079f9ef25b189a
First added on: May 08, 2024